This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Explore the retirement accounts that yield the highest returns. Make informed decisions to grow your retirement savings effectively.
25,325 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Pete Davidson has trimmed the price of his Westchester home to $2.15 million as he eyes a move to Staten Island, sign...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Market chatter centers on Caterpillar as a top pick amid rising oil demand, renewed infrastructure spending, and a su...
The CLARITY Act cleared the Senate Banking Committee, advancing a path toward floor consideration and a broader regul...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
When a stock suddenly pops, traders buzz and headlines flare. This guide breaks down why those moves happen, how to t...
In May, sweetgreen stock jumped 45% as the company signaled a path to recovery. This article breaks down the catalyst...
A formerly troubled telehealth stock is catching fresh attention from investors. This article explores the bull case,...
Artificial intelligence is delivering measurable efficiency in health care, but the race now focuses on who benefits—...
Micron is set to report earnings in June, and investors are laser-focused on a single number that could redefine MU’s...